Donald Reeves III Sells 293 Shares of Itron (NASDAQ:ITRI) Stock

Itron, Inc. (NASDAQ:ITRIGet Free Report) SVP Donald Reeves III sold 293 shares of Itron stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $84.50, for a total transaction of $24,758.50. Following the completion of the sale, the senior vice president directly owned 28,807 shares in the company, valued at approximately $2,434,191.50. The trade was a 1.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Itron Stock Down 1.3%

Shares of NASDAQ:ITRI opened at $82.48 on Friday. The company has a market cap of $3.66 billion, a price-to-earnings ratio of 13.15, a PEG ratio of 0.73 and a beta of 1.35. The firm’s 50-day simple moving average is $87.71 and its 200-day simple moving average is $93.73. The company has a quick ratio of 2.24, a current ratio of 2.66 and a debt-to-equity ratio of 0.97. Itron, Inc. has a fifty-two week low of $77.77 and a fifty-two week high of $142.00.

Itron (NASDAQ:ITRIGet Free Report) last issued its earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.23. The business had revenue of $586.98 million for the quarter, compared to the consensus estimate of $572.04 million. Itron had a net margin of 12.31% and a return on equity of 19.54%. The business’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.52 earnings per share. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. As a group, equities research analysts predict that Itron, Inc. will post 6.01 earnings per share for the current year.

Institutional Trading of Itron

Several hedge funds and other institutional investors have recently made changes to their positions in ITRI. Impax Asset Management Group plc lifted its stake in shares of Itron by 127.3% in the third quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock valued at $197,153,000 after purchasing an additional 890,040 shares during the period. Norges Bank acquired a new stake in shares of Itron in the fourth quarter valued at about $63,990,000. Soros Fund Management LLC acquired a new stake in shares of Itron in the fourth quarter valued at about $34,843,000. Millennium Management LLC lifted its stake in shares of Itron by 269.3% in the fourth quarter. Millennium Management LLC now owns 506,867 shares of the scientific and technical instruments company’s stock valued at $47,068,000 after purchasing an additional 369,617 shares during the period. Finally, Merewether Investment Management LP lifted its stake in shares of Itron by 1,552.7% in the second quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company’s stock valued at $39,593,000 after purchasing an additional 282,587 shares during the period. Institutional investors and hedge funds own 96.19% of the company’s stock.

Wall Street Analyst Weigh In

ITRI has been the topic of several analyst reports. Roth Mkm reaffirmed a “buy” rating and issued a $136.00 target price on shares of Itron in a report on Wednesday, April 29th. Oppenheimer lifted their target price on shares of Itron from $133.00 to $135.00 and gave the company an “outperform” rating in a report on Thursday, April 16th. TD Cowen lowered their target price on shares of Itron from $145.00 to $130.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. Robert W. Baird set a $128.00 target price on shares of Itron and gave the company an “outperform” rating in a report on Wednesday, February 18th. Finally, Stephens reaffirmed an “overweight” rating and issued a $130.00 target price on shares of Itron in a report on Wednesday, May 20th. Eight investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $131.22.

Read Our Latest Research Report on ITRI

Itron Company Profile

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

See Also

Insider Buying and Selling by Quarter for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.